▶ 調査レポート

世界のナノ粒子市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Nanoparticles Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界のナノ粒子市場規模・現状・予測(2021年-2027年) / Global Nanoparticles Market Size, Status and Forecast 2021-2027 / QYR2104Z4011資料のイメージです。• レポートコード:QYR2104Z4011
• 出版社/出版日:QYResearch / 2021年4月
※2025年版があります。お問い合わせください。

• レポート形態:英文、PDF、92ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥546,000 (USD3,900)▷ お問い合わせ
  Multi User/Five User¥819,000 (USD5,850)▷ お問い合わせ
  Enterprise License(同一法人内共有可)¥1,092,000 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査資料では、ナノ粒子のグローバル市場(2016年~2027年)について調べ、市場動向、主要企業の市場シェア、種類別市場規模(リポソーム、ポリマー結合薬、高分子ナノ粒子、デンドリマー、無機ナノ粒子、その他)、用途別市場規模(病院、外来手術センター、診断センター)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、関連企業情報などを掲載しています。
・市場概要
・ナノ粒子の市場動向
・企業の競争状況、市場シェア
・ナノ粒子の種類別市場規模(リポソーム、ポリマー結合薬、高分子ナノ粒子、デンドリマー、無機ナノ粒子、その他)
・ナノ粒子の用途別市場規模(病院、外来手術センター、診断センター)
・ナノ粒子の北米市場規模2016-2027(アメリカ、カナダ)
・ナノ粒子のヨーロッパ市場規模2016-2027(ドイツ、フランス、イギリス等)
・ナノ粒子のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・ナノ粒子の中南米市場規模2016-2027(メキシコ、ブラジル)
・ナノ粒子の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Novartis、Gilead Sciences、Johnson & Johnson、Amgen、Sigma-Tau Pharmaceuticals、Abraxis Biosciences、Nano Interface Technology)
・結論

A nanoparticle is an individual molecule that behaves as a whole unit in terms of its transport and properties. The particle size of nanoparticles is 1 to 100 nanometers. The nanoparticles are further classified according to diameter as ultrafine particles (between 1 and 100 nanometers in size), fine particles (between 100 and 2,500 nanometers), and coarse particles (2,500 and 10,000 nanometers).
Due to a wide variety of potential applications in biomedical, optical, and electronic fields the nanoparticle research is currently an area of intense scientific research. There are various applications of nanoparticles in drug delivery. Nanotechnology is widely used in the health care industry in applications such as neurology, anti-infective, cardiovascular disorders, and others. The expanding medical diagnostics industry, increasing growth in advance healthcare technology and high advantages in medicinal imaging applications are some of the key drivers that are fuelling the growth of global nanoparticles market.

Market Analysis and Insights: Global Nanoparticles Market
The global Nanoparticles market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nanoparticles market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nanoparticles market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nanoparticles market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nanoparticles market.

Global Nanoparticles Scope and Market Size
Nanoparticles market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Nanoparticles market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Liposomes
Polymer-Conjugated Drugs
Polymeric Nanoparticles
Dendrimers
Inorganic Nanoparticles
Others

Segment by Application
Hospitals
Ambulatory Surgery Centers
Diagnostic Centers

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novartis
Gilead Sciences
Johnson & Johnson
Amgen
Sigma-Tau Pharmaceuticals
Abraxis Biosciences
Nano Interface Technology

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nanoparticles Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Liposomes
1.2.3 Polymer-Conjugated Drugs
1.2.4 Polymeric Nanoparticles
1.2.5 Dendrimers
1.2.6 Inorganic Nanoparticles
1.2.7 Others
1.3 Market by Application
1.3.1 Global Nanoparticles Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgery Centers
1.3.4 Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Nanoparticles Market Perspective (2016-2027)
2.2 Nanoparticles Growth Trends by Regions
2.2.1 Nanoparticles Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Nanoparticles Historic Market Share by Regions (2016-2021)
2.2.3 Nanoparticles Forecasted Market Size by Regions (2022-2027)
2.3 Nanoparticles Industry Dynamic
2.3.1 Nanoparticles Market Trends
2.3.2 Nanoparticles Market Drivers
2.3.3 Nanoparticles Market Challenges
2.3.4 Nanoparticles Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Nanoparticles Players by Revenue
3.1.1 Global Top Nanoparticles Players by Revenue (2016-2021)
3.1.2 Global Nanoparticles Revenue Market Share by Players (2016-2021)
3.2 Global Nanoparticles Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Nanoparticles Revenue
3.4 Global Nanoparticles Market Concentration Ratio
3.4.1 Global Nanoparticles Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nanoparticles Revenue in 2020
3.5 Nanoparticles Key Players Head office and Area Served
3.6 Key Players Nanoparticles Product Solution and Service
3.7 Date of Enter into Nanoparticles Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Nanoparticles Breakdown Data by Type
4.1 Global Nanoparticles Historic Market Size by Type (2016-2021)
4.2 Global Nanoparticles Forecasted Market Size by Type (2022-2027)

5 Nanoparticles Breakdown Data by Application
5.1 Global Nanoparticles Historic Market Size by Application (2016-2021)
5.2 Global Nanoparticles Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Nanoparticles Market Size (2016-2027)
6.2 North America Nanoparticles Market Size by Type
6.2.1 North America Nanoparticles Market Size by Type (2016-2021)
6.2.2 North America Nanoparticles Market Size by Type (2022-2027)
6.2.3 North America Nanoparticles Market Size by Type (2016-2027)
6.3 North America Nanoparticles Market Size by Application
6.3.1 North America Nanoparticles Market Size by Application (2016-2021)
6.3.2 North America Nanoparticles Market Size by Application (2022-2027)
6.3.3 North America Nanoparticles Market Size by Application (2016-2027)
6.4 North America Nanoparticles Market Size by Country
6.4.1 North America Nanoparticles Market Size by Country (2016-2021)
6.4.2 North America Nanoparticles Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Nanoparticles Market Size (2016-2027)
7.2 Europe Nanoparticles Market Size by Type
7.2.1 Europe Nanoparticles Market Size by Type (2016-2021)
7.2.2 Europe Nanoparticles Market Size by Type (2022-2027)
7.2.3 Europe Nanoparticles Market Size by Type (2016-2027)
7.3 Europe Nanoparticles Market Size by Application
7.3.1 Europe Nanoparticles Market Size by Application (2016-2021)
7.3.2 Europe Nanoparticles Market Size by Application (2022-2027)
7.3.3 Europe Nanoparticles Market Size by Application (2016-2027)
7.4 Europe Nanoparticles Market Size by Country
7.4.1 Europe Nanoparticles Market Size by Country (2016-2021)
7.4.2 Europe Nanoparticles Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Nanoparticles Market Size (2016-2027)
8.2 Asia-Pacific Nanoparticles Market Size by Type
8.2.1 Asia-Pacific Nanoparticles Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Nanoparticles Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Nanoparticles Market Size by Type (2016-2027)
8.3 Asia-Pacific Nanoparticles Market Size by Application
8.3.1 Asia-Pacific Nanoparticles Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Nanoparticles Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Nanoparticles Market Size by Application (2016-2027)
8.4 Asia-Pacific Nanoparticles Market Size by Region
8.4.1 Asia-Pacific Nanoparticles Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Nanoparticles Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Nanoparticles Market Size (2016-2027)
9.2 Latin America Nanoparticles Market Size by Type
9.2.1 Latin America Nanoparticles Market Size by Type (2016-2021)
9.2.2 Latin America Nanoparticles Market Size by Type (2022-2027)
9.2.3 Latin America Nanoparticles Market Size by Type (2016-2027)
9.3 Latin America Nanoparticles Market Size by Application
9.3.1 Latin America Nanoparticles Market Size by Application (2016-2021)
9.3.2 Latin America Nanoparticles Market Size by Application (2022-2027)
9.3.3 Latin America Nanoparticles Market Size by Application (2016-2027)
9.4 Latin America Nanoparticles Market Size by Country
9.4.1 Latin America Nanoparticles Market Size by Country (2016-2021)
9.4.2 Latin America Nanoparticles Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Nanoparticles Market Size (2016-2027)
10.2 Middle East & Africa Nanoparticles Market Size by Type
10.2.1 Middle East & Africa Nanoparticles Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Nanoparticles Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Nanoparticles Market Size by Type (2016-2027)
10.3 Middle East & Africa Nanoparticles Market Size by Application
10.3.1 Middle East & Africa Nanoparticles Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Nanoparticles Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Nanoparticles Market Size by Application (2016-2027)
10.4 Middle East & Africa Nanoparticles Market Size by Country
10.4.1 Middle East & Africa Nanoparticles Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Nanoparticles Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Nanoparticles Introduction
11.1.4 Novartis Revenue in Nanoparticles Business (2016-2021)
11.1.5 Novartis Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Details
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences Nanoparticles Introduction
11.2.4 Gilead Sciences Revenue in Nanoparticles Business (2016-2021)
11.2.5 Gilead Sciences Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Nanoparticles Introduction
11.3.4 Johnson & Johnson Revenue in Nanoparticles Business (2016-2021)
11.3.5 Johnson & Johnson Recent Development
11.4 Amgen
11.4.1 Amgen Company Details
11.4.2 Amgen Business Overview
11.4.3 Amgen Nanoparticles Introduction
11.4.4 Amgen Revenue in Nanoparticles Business (2016-2021)
11.4.5 Amgen Recent Development
11.5 Sigma-Tau Pharmaceuticals
11.5.1 Sigma-Tau Pharmaceuticals Company Details
11.5.2 Sigma-Tau Pharmaceuticals Business Overview
11.5.3 Sigma-Tau Pharmaceuticals Nanoparticles Introduction
11.5.4 Sigma-Tau Pharmaceuticals Revenue in Nanoparticles Business (2016-2021)
11.5.5 Sigma-Tau Pharmaceuticals Recent Development
11.6 Abraxis Biosciences
11.6.1 Abraxis Biosciences Company Details
11.6.2 Abraxis Biosciences Business Overview
11.6.3 Abraxis Biosciences Nanoparticles Introduction
11.6.4 Abraxis Biosciences Revenue in Nanoparticles Business (2016-2021)
11.6.5 Abraxis Biosciences Recent Development
11.7 Nano Interface Technology
11.7.1 Nano Interface Technology Company Details
11.7.2 Nano Interface Technology Business Overview
11.7.3 Nano Interface Technology Nanoparticles Introduction
11.7.4 Nano Interface Technology Revenue in Nanoparticles Business (2016-2021)
11.7.5 Nano Interface Technology Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Nanoparticles Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Liposomes
Table 3. Key Players of Polymer-Conjugated Drugs
Table 4. Key Players of Polymeric Nanoparticles
Table 5. Key Players of Dendrimers
Table 6. Key Players of Inorganic Nanoparticles
Table 7. Key Players of Others
Table 8. Global Nanoparticles Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Nanoparticles Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Nanoparticles Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Nanoparticles Market Share by Regions (2016-2021)
Table 12. Global Nanoparticles Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Nanoparticles Market Share by Regions (2022-2027)
Table 14. Nanoparticles Market Trends
Table 15. Nanoparticles Market Drivers
Table 16. Nanoparticles Market Challenges
Table 17. Nanoparticles Market Restraints
Table 18. Global Nanoparticles Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Nanoparticles Market Share by Players (2016-2021)
Table 20. Global Top Nanoparticles Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanoparticles as of 2020)
Table 21. Ranking of Global Top Nanoparticles Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Nanoparticles Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Nanoparticles Product Solution and Service
Table 25. Date of Enter into Nanoparticles Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Nanoparticles Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Nanoparticles Revenue Market Share by Type (2016-2021)
Table 29. Global Nanoparticles Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Nanoparticles Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Nanoparticles Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Nanoparticles Revenue Market Share by Application (2016-2021)
Table 33. Global Nanoparticles Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Nanoparticles Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Nanoparticles Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Nanoparticles Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Nanoparticles Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Nanoparticles Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Nanoparticles Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Nanoparticles Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Nanoparticles Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Nanoparticles Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Nanoparticles Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Nanoparticles Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Nanoparticles Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Nanoparticles Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Nanoparticles Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Nanoparticles Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Nanoparticles Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Nanoparticles Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Nanoparticles Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Nanoparticles Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Nanoparticles Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Nanoparticles Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Nanoparticles Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Nanoparticles Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Nanoparticles Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Nanoparticles Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Nanoparticles Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Nanoparticles Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Nanoparticles Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Nanoparticles Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Nanoparticles Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Nanoparticles Market Size by Country (2022-2027) & (US$ Million)
Table 65. Novartis Company Details
Table 66. Novartis Business Overview
Table 67. Novartis Nanoparticles Product
Table 68. Novartis Revenue in Nanoparticles Business (2016-2021) & (US$ Million)
Table 69. Novartis Recent Development
Table 70. Gilead Sciences Company Details
Table 71. Gilead Sciences Business Overview
Table 72. Gilead Sciences Nanoparticles Product
Table 73. Gilead Sciences Revenue in Nanoparticles Business (2016-2021) & (US$ Million)
Table 74. Gilead Sciences Recent Development
Table 75. Johnson & Johnson Company Details
Table 76. Johnson & Johnson Business Overview
Table 77. Johnson & Johnson Nanoparticles Product
Table 78. Johnson & Johnson Revenue in Nanoparticles Business (2016-2021) & (US$ Million)
Table 79. Johnson & Johnson Recent Development
Table 80. Amgen Company Details
Table 81. Amgen Business Overview
Table 82. Amgen Nanoparticles Product
Table 83. Amgen Revenue in Nanoparticles Business (2016-2021) & (US$ Million)
Table 84. Amgen Recent Development
Table 85. Sigma-Tau Pharmaceuticals Company Details
Table 86. Sigma-Tau Pharmaceuticals Business Overview
Table 87. Sigma-Tau Pharmaceuticals Nanoparticles Product
Table 88. Sigma-Tau Pharmaceuticals Revenue in Nanoparticles Business (2016-2021) & (US$ Million)
Table 89. Sigma-Tau Pharmaceuticals Recent Development
Table 90. Abraxis Biosciences Company Details
Table 91. Abraxis Biosciences Business Overview
Table 92. Abraxis Biosciences Nanoparticles Product
Table 93. Abraxis Biosciences Revenue in Nanoparticles Business (2016-2021) & (US$ Million)
Table 94. Abraxis Biosciences Recent Development
Table 95. Nano Interface Technology Company Details
Table 96. Nano Interface Technology Business Overview
Table 97. Nano Interface Technology Nanoparticles Product
Table 98. Nano Interface Technology Revenue in Nanoparticles Business (2016-2021) & (US$ Million)
Table 99. Nano Interface Technology Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nanoparticles Market Share by Type: 2020 VS 2027
Figure 2. Liposomes Features
Figure 3. Polymer-Conjugated Drugs Features
Figure 4. Polymeric Nanoparticles Features
Figure 5. Dendrimers Features
Figure 6. Inorganic Nanoparticles Features
Figure 7. Others Features
Figure 8. Global Nanoparticles Market Share by Application: 2020 VS 2027
Figure 9. Hospitals Case Studies
Figure 10. Ambulatory Surgery Centers Case Studies
Figure 11. Diagnostic Centers Case Studies
Figure 12. Nanoparticles Report Years Considered
Figure 13. Global Nanoparticles Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Nanoparticles Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Nanoparticles Market Share by Regions: 2020 VS 2027
Figure 16. Global Nanoparticles Market Share by Regions (2022-2027)
Figure 17. Global Nanoparticles Market Share by Players in 2020
Figure 18. Global Top Nanoparticles Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanoparticles as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Nanoparticles Revenue in 2020
Figure 20. Global Nanoparticles Revenue Market Share by Type (2016-2021)
Figure 21. Global Nanoparticles Revenue Market Share by Type (2022-2027)
Figure 22. North America Nanoparticles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Nanoparticles Market Share by Type (2016-2027)
Figure 24. North America Nanoparticles Market Share by Application (2016-2027)
Figure 25. North America Nanoparticles Market Share by Country (2016-2027)
Figure 26. United States Nanoparticles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Nanoparticles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Nanoparticles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Nanoparticles Market Share by Type (2016-2027)
Figure 30. Europe Nanoparticles Market Share by Application (2016-2027)
Figure 31. Europe Nanoparticles Market Share by Country (2016-2027)
Figure 32. Germany Nanoparticles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Nanoparticles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Nanoparticles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Nanoparticles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Nanoparticles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Nanoparticles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Nanoparticles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Nanoparticles Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Nanoparticles Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Nanoparticles Market Share by Region (2016-2027)
Figure 42. China Nanoparticles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Nanoparticles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Nanoparticles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Nanoparticles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Nanoparticles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Nanoparticles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Nanoparticles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Nanoparticles Market Share by Type (2016-2027)
Figure 50. Latin America Nanoparticles Market Share by Application (2016-2027)
Figure 51. Latin America Nanoparticles Market Share by Country (2016-2027)
Figure 52. Mexico Nanoparticles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Nanoparticles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Nanoparticles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Nanoparticles Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Nanoparticles Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Nanoparticles Market Share by Country (2016-2027)
Figure 58. Turkey Nanoparticles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Nanoparticles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Nanoparticles Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Novartis Revenue Growth Rate in Nanoparticles Business (2016-2021)
Figure 62. Gilead Sciences Revenue Growth Rate in Nanoparticles Business (2016-2021)
Figure 63. Johnson & Johnson Revenue Growth Rate in Nanoparticles Business (2016-2021)
Figure 64. Amgen Revenue Growth Rate in Nanoparticles Business (2016-2021)
Figure 65. Sigma-Tau Pharmaceuticals Revenue Growth Rate in Nanoparticles Business (2016-2021)
Figure 66. Abraxis Biosciences Revenue Growth Rate in Nanoparticles Business (2016-2021)
Figure 67. Nano Interface Technology Revenue Growth Rate in Nanoparticles Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed